{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Houston",
      "state": "TX",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "72294",
      "recalling_firm": "Tf Supplements",
      "address_1": "6666 Gulf Fwy",
      "address_2": "N/A",
      "postal_code": "77087-1416",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0771-2016",
      "product_description": "RHINO 7 3000, 6 count Bottle, Distributed by Rhino 7, Made in USA",
      "product_quantity": "350 Bottles",
      "reason_for_recall": "Marketed without an Approved NDA/ANDA: Products contain undeclared desmethyl carbondenafil and dapoxetine.",
      "recall_initiation_date": "20150925",
      "center_classification_date": "20160309",
      "termination_date": "20220519",
      "report_date": "20160316",
      "code_info": "All lots"
    }
  ]
}